UnknownPhase 2

Efficacy of Zoledronic Acid in Osteoporosis

Japan100 participantsStarted 2017-10-12

Plain-language summary

There has been no comparative data between Zoledronic acid and Zoledronic acid combined with active vitamin D in primary and secondary osteoporosis.

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Osteoporotic patients who want to take zoledronic acid Exclusion Criteria: * Patients who are allergic to zoledronic acid or vitamin D * Patients who are pregnant or breast-feeding * Patients who have not taken zoledronic acid for the last 2 years

What they're measuring

Bone mineral density

Timeframe: Change from Baseline Values at 1 year

Trial details

NCT IDNCT03183557

SponsorShinshu University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-12-08

Contact for this trial

Yukio Nakamura, MD, PhD

+81-263-37-2659 yxn14@aol.jp

View on ClinicalTrials.gov More Osteoporosis trials